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While outbreaks of animal anthrax zoonoses still regularly occur in France, little is known about the
epidemiology links between them. We have used the eight-locus multilocus variable-number tandem repeat
analysis typing technique against a collection of 50 Bacillus anthracis isolates from France. There were eight
distinct genotypes belonging to two dissimilar genetic clusters. Regional strain patterns were observed, with the
B2 genotypes prevalent in southern France and the A1a genotypes found only in northern France.
Bacillus anthracis is the causal agent of anthrax, a serious
infection in both livestock and humans that is often fatal.
Anthrax is still endemic in many countries. Animals are in-
fected by contact with soilborne spores. Normally, humans are
infected only incidentally, via contact with diseased animals or
their waste products. Unfortunately, recent events have shown
that B. anthracis can also be used in bioterrorism. Virulent
strains of B. anthracis produce toxins and are encapsulated.
These strains have two virulence plasmids, pXO1 and pXO2,
encoding the toxins and the capsule synthetic activity, respec-
tively (3). B. anthracis is one of the most monomorphic patho-
genic bacteria described. Numerous studies have shown that
techniques used to discriminate between strains in other spe-
cies have low discriminatory power within the B. anthracis
strains. Recently, a multilocus variable-number tandem repeat
(VNTR) analysis (MLVA) for the molecular typing of B. an-
thracis strains was developed (1). Short nucleotide sequences
that are repeated multiple times vary in copy number, creating
length polymorphisms. Six such fragments were defined on the
chromosome, and one such fragment was defined on each of
the plasmids. The MLVA has previously defined 89 genetically
distinct types that can be grouped in two major clusters (1).
One cluster (cluster A) is found around the world, whereas the
other one (cluster B) is almost exclusively restricted to south-
ern Africa (1). Outbreaks of animal anthrax zoonoses still
occur fairly regularly in France. A collection, which includes B.
anthracis isolates collected in various regions during the last 20
years, was established (7). In this paper, we report the results
obtained with the MLVA on 50 independent isolates: 36 iso-
lates are from recent episodes of animal anthrax, 13 isolates
are from older, seemingly sporadic animal cases, and 1 isolate
is from a human case.
Geographical and temporal distribution. This study is based
on 49 B. anthracis isolates of animal origin and one of human
origin, isolated after a fatal case of meningitis. The animal
isolates were collected by the CNEVA/LCRV (Central Labo-
ratory of Veterinary Research from 1982 to 1999) or the AFSSA/
LERPAZ (French Food Safety Agency/Research Laboratory
for the study of Animal Pathology and Zoonoses from 1999 to
2002) during etiologic studies performed between 1982 and
2001 on herds with abnormal mortality (4, 7). The majority (36
of 49) were isolated between 1997 and 2001 during epizootic
periods with many outbreaks evolving during 2 to 4 months in
a given region.
The 49 animal isolates originate from 43 different farm es-
tates located in various regions of France (Fig. 1). These iso-
lates were mostly from bovine hosts. Only four isolates were
from other species: three from sheep and one from a dog. Five
isolates were from different animals on the same estate in
southwestern France. Similarly, twice, in the Alps and in Bur-
gundy, two isolates were from two animals of a given farm
estate. This redundant analysis was performed to test whether
the same genotype would be implicated in sick animals from
the same estate.
Essentially all anthrax-affected animals were pasture-raised
livestock. Only two isolates came from animals living in stalls:
one from an animal with no contact with the outside and one
where animals had an area to relax with a beaten-earth floor.
The outbreaks occurred mainly in the spring but also occurred
during the summer and fall. For many outbreaks, the origin has
been correlated with work in soils that had been contaminated
in the past. In other cases, the origin is unclear. However, the
hydrogeological type of the soils seems of great importance in
this study and has been reported previously (2, 5). Also, the
appearance of anthrax is correlated with other diseases that
weaken the victims or create microwounds in the mucous
membranes that act as entry passages for B. anthracis spores
(7).
Genetic diversity of B. anthracis isolates in France. We ex-
amined the genetic diversity of the 50 French B. anthracis
isolates described in the previous paragraph by eight-locus
MLVA (1). Briefly, a single colony was “heat lysed” in Tris-
EDTA (TE) buffer, and the MLVA PCR amplifications were
performed after the cellular debris was removed (1, 6). Diver-
sity group clusters were analyzed by cluster analysis as previ-
ously described (6). Genetic relationships among French B. an-
thracis isolates are graphically presented in Fig. 2.
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We found three dominant and eight distinct MLVA geno-
types. In the A1a type, 17 strains are from the dominant ge-
notype, genotype 3 (GT3 from reference 1). This particular
genotype was found in one outbreak with many cases in the
Bourgogne region in 1999 and 2000 (8 isolates) and in sporadic
cases scattered over many regions between 1982 and 1999 (8
isolates). An isolate with this genotype was isolated in the
human fatal meningitis case, apparently not correlated to any
FIG. 1. Locations of B. anthracis isolates. This map shows the regions where isolates of B. anthracis were obtained for this genetic study. The
actual collection sites are indicated by the small solid black dots. The labels indicate the number of isolates from a location, the genotype (GT),
and the year the isolate was collected [e.g., 1 GT3 (1985)]. The red GT numbers are from cluster B2, while the blue GT numbers are from cluster
A1a in Fig. 2. Intercarto map adapted with permission.
FIG. 2. Genetic relationships among French B. anthracis isolates. The dendrogram based upon eight VNTR marker loci and unweighted paired
group means analysis cluster analysis illustrates the genetic relationships among isolates. The genotype (GT) designations are consistent with those
of Keim et al. (1), with the exception of three novel types observed in this study (GT1a, GT1b, and GT20a), which are labeled with asterisks. The
number of each genotype and the actual allele size (in nucleotides) are shown to the right of the dendrogram.
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animal outbreak. GT3 is the most common type seen in North
America, especially in the United States, and also the most
common from France (Fig. 2) (1). This wide distribution also
holds for the individual regions across North America and
France and in South America (1). However, the French B.
anthracis GT3 genotype was not found either in the Rhoˆne-
Alpes or in the Pyre´ne´es (Aquitaine region).
The five other genotypes from the A1a cluster are extremely
rare and were found only once or twice. The GT6 (two iso-
lates) and GT1 (one isolate) genotypes were found in the
Centre Province during sporadic cases in 1984 and 1986. It is
noteworthy that three genotypes had not been previously de-
scribed (GT1a, GT1b, and GT20a) and that each of these
genotypes is represented by a single isolate from sporadic
cases. They were observed at various geographical areas and
times (Picardie in 1989, Aquitaine in 1990, and Bourgogne in
1999).
The two other genotypes that are dominant in France are
extremely rare in the world (1) and belong to the B2 cluster.
The B2 cluster is a distinct clonal lineage that has been ob-
served only twice previously, once from Slovakia and once
from Croatia. GT79 was regularly and exclusively found in
anthrax episodes occurring in the Alps in 1997 and 2000 (12
isolates) and from the summer pastures in Auvergne in 1992,
2000, and 2001 (3 isolates). GT80 has been found only in
outbreaks from the Pyre´ne´es in 1992 (1 isolate), 1994 (1 iso-
late), and 1997 (10 isolates). Thus, the B2 genetic type is nearly
exclusively French in origin. Because of the longevity of spores
and the ready transport of spore-contaminated material, few
genotypes are seen in a single region. The restricted distribu-
tion of the B2 cluster is unique in this regard.
The dominant French GT3 genotype is genetically quite
dissimilar to the B2 types with six (A1a versus B2 GT80) and
seven (A1a versus B2 GT79) different alleles among the eight
MLVA markers. The only marker that does not differ between
these two types is vvrB, which is in fact the same in all French
isolates. In this set of isolates, similar to what was found in the
worldwide study, the pXO1 marker is the most discriminatory,
with a diversity index value (D) of 0.55. However, the pXO2
marker differs only in the GT79 and GT80 isolates and repre-
sents the marker that differentiates the B2 subgroup (D 
0.42). This situation is the opposite of that encountered during
the other study describing type A and B B. anthracis in a
limited geographical area, namely, the Kruger National Park
(6). In that case, the pXO2 marker had the same allele, while
the pXO1 marker differed.
While the VNTR loci examined in this study are some of the
most diverse regions in the B. anthracis genome, they are
relatively stable in epidemics. The large and ongoing anthrax
epidemic in Canadian bison populations is an example where
these eight loci are unchanged across hundreds of kilometers
and decades of time (1). Laboratory studies to detect and
characterize mutations at these loci have been performed, and
very few mutations are observed despite extensive passages
(data not presented). In one experiment, the 96 independent
cultures of the Sterne strain were transferred 40 times, and
only one mutation was observed (G. Zinser and P. Keim,
unpublished data). Laboratory transfer experiments are lim-
ited by their logistics and will be able to characterize only
mutational processes acting at very high rates (e.g., 105
mutation per generation). MLVA genotypes with different al-
leles at multiple loci must be separated by relatively great
evolutionary distances.
Given the great genetic distance between the genotype A
and B branches, it seems likely that B. anthracis currently
active in France has been introduced in at least two events.
This conclusion is based upon the two dominant types and
their distinct genetic relationship. Given the great evolutionary
distance between the A1a and B2 clusters, in situ differentia-
tion seems unlikely. The prevalence of GT3 in France and its
common occurrence in North America also suggest an epide-
miological link between these two regions. It seems plausible
that the dominant form of North American B. anthracis was
introduced from Europe.
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